Reference
Reference TypeLiterature
TitleDiscordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
AuthorsMarina A Durward; Jerome Harms; Diogo M Magnani; Linda Eskra; Gary A Splitter
AffiliationsDepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA.
JournalInfect Immun
Year2010
AbstractBrucella spp. are intracellular bacteria that cause the most frequent zoonosis in the world. Although recent work has advanced the field of Brucella vaccine development, there remains no safe human vaccine. In order to produce a safe and effective human vaccine, the immune response to Brucella spp. requires greater understanding. Induction of Brucella-specific CD8+ T cells is considered an important aspect of the host response; however, the CD8+ T-cell response is not clearly defined. Discovering the epitope containing antigens recognized by Brucella-specific CD8+ T cells and correlating them with microarray data will aid in determining proteins critical for vaccine development that cover a kinetic continuum during infection. Developing tools to take advantage of the BALB/c mouse model of Brucella melitensis infection will help to clarify the correlates of immunity and improve the efficacy of this model. Two H-2(d) CD8+ T-cell epitopes have been characterized, and a group of immunogenic proteins have provoked gamma interferon production by CD8+ T cells. RYCINSASL and NGSSSMATV induced cognate CD8+ T cells after peptide immunization that showed specific killing in vivo. Importantly, we found by microarray analysis that the genes encoding these epitopes are differentially expressed following macrophage infection, further emphasizing that these discordant genes may play an important role in the pathogenesis of B. melitensis infection.
Curation Last Updated2023-08-18 20:50:08
Epitope
Epitope ID122566
Chemical TypeLinear peptide
Linear SequenceRYCINSASL
Source Molecule NamePeptide methionine sulfoxide reductase msrB
Source OrganismBrucella melitensis
Starting Position116
Ending Position124
Epitope Reference Details
Epitope Structure DefinesExact Epitope
Epitope NameBMEII0819 - Peptide 2
Location of Data in ReferenceTable 1
Immunization
Host OrganismMus musculus BALB/c
Host Details
SexF
Age6-8 weeks
1st In Vivo Process
In Vivo Process TypeAdministration in vivo
Administration Details
AdjuvantsFreund's incomplete (IFA);VO:0000142
Routesubcutaneous
Dose Schedule1 dose of 50 ug
1st Immunogen
Epitope RelationEpitope
Chemical TypeLinear peptide
Linear SequenceRYCINSASL
Source Molecule NamePeptide methionine sulfoxide reductase msrB
Source OrganismBrucella melitensis
Starting Position116
Ending Position124
Immunization Comments
Immunization CommentsMice were immunized with a pool of 10 peptides (50 ug each peptide) including the epitope.
T Cell Assay
Qualitative MeasurementPositive-Low
Method/TechniqueICS
Measurement ofIFNg release
Effector Cells
Effector Cell Tissue TypeSpleen
Effector Cell TypeT cell CD8+
Effector Cell Culture ConditionsDirect Ex Vivo
Antigen Presenting Cells
Cell Tissue TypeSpleen
Cell TypeSplenocyte
Cell Culture ConditionsDirect Ex Vivo
MHC Allele
MHC Allele NameH2-Kd
MHC Evidence CodeMHC binding assay
Antigen
Epitope RelationEpitope
Chemical TypeLinear peptide
Linear SequenceRYCINSASL
Source Molecule NamePeptide methionine sulfoxide reductase msrB
Source OrganismBrucella melitensis
Starting Position116
Ending Position124
Assay Reference Details
Location of Assay Data in ReferenceFigure 1, Table 1